| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Third Department of Internal Medicine Yamanashi Medical University Tamaho, Yamanashi 40938, Japan
The GA-binding protein (GABP), a transcription
factor with a widespread tissue distribution, consists of two subunits,
and ß1, and acts as a potent positive regulator of various genes.
The effect of GABP on transcription of the TSH receptor (TSHR) gene in
rat FRTL-5 thyroid cells has now been investigated. Both
deoxyribonuclease I footprint analysis and gel mobility-shift assays
indicated that bacterially expressed glutathione
S-transferase fusion proteins of GABP subunits bind to a
region spanning nucleotides (nt) -116 to -80 of the TSHR gene. In gel
mobility-shift assays, nuclear extracts of FRTL-5 cells and FRT cells
yielded several specific bands with a probe comprising nt -116 to
-80. Supershift assays with antibodies to GABP
and to GABPß1
showed that GABP was a component of the probe complexes formed by the
nuclear extracts. Immunoblot analysis confirmed the presence of both
GABP subunits in the nuclear extracts. A reporter gene construct
containing the TSHR gene promoter was activated, in a dose-dependent
manner, in FRTL-5 cells by cotransfection with constructs encoding both
GABP
and GABPß1. Both GABP binding to and activation of the TSHR
gene promoter were prevented by methylation of CpG sites at nt -93 and
-85.
These CpG sites were highly methylated (>82%) in FRT cells and completely demethylated in FRTL-5 cells, consistent with expression of the TSHR gene in the latter, but not the former. These results suggest that GABP regulates transcription of the TSHR gene in a methylation-dependent manner and that methylation of specific CpG sites and the methylation sensitivity of GABP contribute to the failure of FRT cells to express the endogenous TSHR gene.
This article has been cited by other articles:
![]() |
M. Xing BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications Endocr. Rev., December 1, 2007; 28(7): 742 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lin, P. J. Collins, N. D. Trinklein, Y. Fu, H. Xi, R. M. Myers, and Z. Weng Transcription factor binding and modified histones in human bidirectional promoters Genome Res., June 1, 2007; 17(6): 818 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xing Gene Methylation in Thyroid Tumorigenesis Endocrinology, March 1, 2007; 148(3): 948 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Smith, R. D. Nicholls, and D. Reines The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors Nucleic Acids Res., February 25, 2006; 34(4): 1205 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xing, H. Usadel, Y. Cohen, Y. Tokumaru, Z. Guo, W. B. Westra, B. C. Tong, G. Tallini, R. Udelsman, J. A. Califano, et al. Methylation of the Thyroid-stimulating Hormone Receptor Gene in Epithelial Thyroid Tumors: A Marker of Malignancy and a Cause of Gene Silencing Cancer Res., May 1, 2003; 63(9): 2316 - 2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimura, H. Suzuki, A. Miyazaki, F. Furuya, K. Ohta, K. Haraguchi, T. Endo, and T. Onaya Transcriptional Activation of the Thyroglobulin Promoter Directing Suicide Gene Expression by Thyroid Transcription Factor-1 in Thyroid Cancer Cells Cancer Res., May 1, 2001; 61(9): 3640 - 3646. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |